Radiologic response to TACE-RT as a prognostic factor in advanced HCC with macroscopic vascular invasionJanuary 20, 2022Hepatocellular Carcinoma
HAIC-FO outperforms sorafenib against advanced HCC in phase 3January 20, 2022Hepatocellular Carcinoma
Atezolizumab + bevacizumab shows long-term benefits over sorafenib for unresectable HCCJanuary 20, 2022Hepatocellular Carcinoma
No survival benefits with first-line nivolumab vs sorafenib in advanced HCCJanuary 20, 2022Hepatocellular Carcinoma
Advanced HCC: Data spanning 15 years shows significant improvement in clinical outcomes with sorafenibJanuary 19, 2022Hepatocellular Carcinoma
How can the patient response and outcome to drug-eluting bead TACE for HCC be predicted?January 19, 2022Hepatocellular Carcinoma
Microwave ablation as a possible real-world replacement for radiofrequency ablation in HCCJanuary 19, 2022Hepatocellular Carcinoma
HIAC vs TACE: The better initial therapy for infiltrative HCC?January 19, 2022Hepatocellular Carcinoma
mRECIST objective response and early tumor shrinkage predict survival in sorafenib-treated HCCJanuary 19, 2022Hepatocellular Carcinoma
HCC: AFP <500 ng/mL at liver transplant even in patients with moderately elevated AFP may mend posttransplant outcomesJanuary 19, 2022Hepatocellular Carcinoma
Persistent and incident body fatness is strongly associated with HCC developmentJanuary 19, 2022Hepatocellular Carcinoma
Surgery vs radiofrequency ablation: Achieving better recurrence-free survival in small HCCJanuary 19, 2022Hepatocellular Carcinoma
ABO blood group system may dictate the outcome of liver transplantation in HCCJanuary 19, 2022Hepatocellular Carcinoma
Clinical Edge Journal Scan Commentary: EPI December 2021December 10, 2021Exocrine Pancreatic Insufficiency
